The
global transgenic animal market is anticipated to observe an impressive growth
during the forecast period, 2023-2027. The major factors include increasing
consumption of animal-derived protein and dairy products and rise in R&D
activities. A transgenic animal is one who's genes are modified to improve both
quality and quantity of food demand and also help to understand gene disease.
The other factors supporting the market's growth are rise various diseases,
advancement in techniques, and growing awareness. Additionally, rising healthcare expenditure and implementation of the animal welfare regulations are driving the
growth of the market in upcoming years.
Increasing
Consumption of Animal-Derived Protein and Dairy Products
As
protein and calcium plays a vital role in nutrition, the consumption of meat
and meat products such as dairy products, eggs, beef, and chicken are
increasing, which surge the market growth in foreseen years. For instance,
genetically modified poultry, such as broilers, have high number of proteins
which are easily digestible. Additionally, rapid urbanization and increase
in population across the globe are bolstering the market growth. Owing to the increase
in animal derived protein supplements and food products, the need for
transgenic animals is also rising. Therefore, all these factors are propelling
the growth of the transgenic animal market, globally. In 2015, a study by
Meat and Livestock in Australia revealed that genetically modified cows can
produce more milk and are less susceptible to cattle diseases.
Wide
Applications of Transgenic Animals
Transgenic
animals have numerous applications in various fields such as agriculture,
medical and industrial sectors. They are used to develop new and improved
strains of livestock and as model organisms. Development of transgenic farm
animals are allowing more flexibility in direct genetic manipulation of
livestock. With ever-growing world population and changing climate conditions,
such efficient means of increasing food production are needed. In addition,
transgenic animals are specifically designed to study the genes in order to
develop a cure for the diseases such as Alzheimer’s and cancer. For instance,
in 2020, Merck Animal Health along with Automazioni VX, Inc. (US) signed an
agreement aiming to Innoject Pro, a newly designed subcutaneous chick
vaccination technology. The technology will be utilized by coupling with Merck
Animal Health’s Innovax range of vaccines, which aids for protection against
infectious diseases.
Increasing
awareness and R&D Initiatives
Various
R&D initiatives and awareness programs are initiated by the governments of
the respective countries, which is bolstering the growth of the transgenic
market. As per a publication by the British Nutrition Foundation 2018,
genetically modified cows were anticipated to produce milk without
allergy-producing protein, which will make the product apt for
lactose-intolerant people. As per the National Institute of Health, in 2017,
approximately 8% of the population in the U.K. was suffering from lactose
intolerance. Thus, the modifications are likely to provide newer prospects
for animal genetics in the upcoming years. Furthermore, the rising initiative
to educate on transgenic animal is further anticipated to drive the growth of
this market.
Download Free Sample Report
Market Segmentation
The global transgenic animal
market is segmented into product,
PCR, technique, application, model organism, end user and company. Based on product, the market is divided into gene gun,
PCR, microinjections, and others. Based on PCR, the market is divided
into real-time PCR, digital PCR System, and others.
Based on technique, the market is segmented into
DNA
microinjection, embryonic stem cell-mediated gene transfer, retrovirus-mediated
gene transfer, and others. Based
on application, the market is segmented into recombinant human proteins,
monoclonal antibodies, xenotransplantation, and others. Based on model
organisms, the market is segmented into mice, rabbit, cow, and others. Based on
end user, the market is segmented into biotechnology & pharmaceutical
companies, academic & research organizations, and others. In
terms of country, the United States is expected to be a lucrative market in the
forecast period due to rising animal-based protein food and growing occurrence
of diseases in the country.
Market Players Merck
& Co., Inc., C.H. Boehringer Sohn Ko. KG, Randox Laboratories Limited, Zoetis,
Inc., Virbac SA, Elanco Animal Health Inc., Biogénesis Bagó SA, Santa Cruz Biotechnology,
Inc, Idexx Laboratories, Inc., and Innovative Diagnostics (IDVet) are some of the leading companies
operating in the market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 – 2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023 – 2027
|
|
Quantitative Units
|
Revenue in USD Million, Volume Units and
CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue forecast, Volume forecast company share, competitive
landscape, growth factors, and trends
|
|
Segments covered
|
·
Product
o
PCR
·
Technique
·
Application
·
Model Organism
·
End User
·
Company
|
|
Regional scope
|
North America; Asia Pacific; Europe & CIS; South America;
Middle East & Africa
|
|
Country scope
|
United States; Canada; Mexico; China;
India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil;
Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa
|
|
Key companies profiled
|
C.H. Boehringer Sohn Ko. KG, ELIAS Animal Health, LLC, Zoetis
Inc., AB Science S.A., Karyopharm Therapeutics, Inc., Vivesto AB, Merial
Inc., Elanco Animal Health, Inc., Dechra Pharmaceuticals PLC (Anivive
Lifesciences), and Torigen Pharmaceuticals Inc
|
|
Customization scope
|
10% free report customization with
purchase. Addition or alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, global transgenic
animal market has been segmented into following categories, in addition to the industry
trends which have also been detailed below:
·
Transgenic Animal Market, By Product:
§
Real-Time
PCR
§
Digital
PCR Systems
§
Others
·
Transgenic Animal Market, By Technique:
- DNA Microinjection
- Embryonic Stem Cell-Mediated
Gene Transfer
- Retrovirus-Mediated
Gene Transfer
- Others
·
Transgenic Animal Market, By Application:
- Recombinant Human Proteins
- Monoclonal Antibodies
- Xenotransplantation
- Others
·
Transgenic Animal Market, By Model Organisms:
·
Transgenic Animal Market, By End User:
- Biotechnology & Pharmaceutical Companies
- Academic & Research Organizations
- Others
·
Transgenic Animal Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
§
South
Africa
§
Saudi
Arabia
§
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present in Transgenic Animal Market
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market
players (up to five).
Global Transgenic Animal
Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]